{"id":{"repo_id":"uiuc","oai_identifier":"oai:www.ideals.illinois.edu:2142/87133"},"canonical_url":"https://search.dev.ndltd.org/etd/uiuc/oai:www.ideals.illinois.edu:2142/87133","repository":{"repo_id":"uiuc","name":"University of Illinois - Urbana-Champaign","base_url":"https://www.ideals.illinois.edu/oai-pmh"},"display":{"title":"The Participation of Transforming Growth Factor Beta in Tumor Immunoevasion","abstract":"In addition to exploring the clinical utility of combination cytokine therapies for the treatment of cancer, our studies also investigate the molecular mechanisms which participate in the generation of peripheral CD8+CD25 + T regulatory cells. Our findings suggest that in the presence of high concentrations of TGFbeta1, strong costimulatory strength is permissive for the induction of CD8+ T cells possessing suppressor functions. Our studies also demonstrate that the adoptive transfer of peripherally-induced regulatory CD8+ T cells into recipient mice may allow for the acceleration of pulmonary metastatic disease, suggesting that CD8+ T regulatory cells are capable of antagonizing antitumor immune responses in mice bearing metastatic melanoma. The findings from these collective studies advance our understanding of how antitumor immune responses may be enhanced through cytokine manipulation strategies, and characterize the molecular signals involved in peripheral CD8+ regulatory T cell development.","abstract_html":"In addition to exploring the clinical utility of combination cytokine therapies for the treatment of cancer, our studies also investigate the molecular mechanisms which participate in the generation of peripheral CD8+CD25 + T regulatory cells. Our findings suggest that in the presence of high concentrations of TGFbeta1, strong costimulatory strength is permissive for the induction of CD8+ T cells possessing suppressor functions. Our studies also demonstrate that the adoptive transfer of peripherally-induced regulatory CD8+ T cells into recipient mice may allow for the acceleration of pulmonary metastatic disease, suggesting that CD8+ T regulatory cells are capable of antagonizing antitumor immune responses in mice bearing metastatic melanoma. The findings from these collective studies advance our understanding of how antitumor immune responses may be enhanced through cytokine manipulation strategies, and characterize the molecular signals involved in peripheral CD8+ regulatory T cell development.","abstract_has_math":false,"creators":["Fan, Timothy M."],"institution":"University of Illinois at Urbana-Champaign","degree_name":"Ph.D.","degree_level":"Dissertation","degree_discipline":"Veterinary Clinical Medicine","degree_department":null,"school":null,"contributors":["Roy, Edward J."],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2015,"date_issued":"2015-09-28T15:38:29Z","date_published":"2015-09-28T15:38:29Z","updated_at":"2026-07-22T22:26:28Z","subjects":["Health Sciences, Oncology"],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["(MiAaPQ)AAI3269890"],"render_values":[{"text":"(MiAaPQ)AAI3269890","href":null,"code":true}]}]},"links":{"outbound_url":"http://hdl.handle.net/2142/87133","outbound_label":"Handle","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Roy, Edward J."]},{"key":"dc:creator","label":"Author","values":["Fan, Timothy M."]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2015-09-28T15:38:29Z","10000-01-01","2007"]},{"key":"dc:type","label":"Dc Type","values":["text"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Veterinary Clinical Medicine"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Dissertation"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Ph.D."]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["University of Illinois at Urbana-Champaign"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Health Sciences, Oncology"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["eng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["http://hdl.handle.net/2142/87133","(MiAaPQ)AAI3269890"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["In addition to exploring the clinical utility of combination cytokine therapies for the treatment of cancer, our studies also investigate the molecular mechanisms which participate in the generation of peripheral CD8+CD25 + T regulatory cells. Our findings suggest that in the presence of high concentrations of TGFbeta1, strong costimulatory strength is permissive for the induction of CD8+ T cells possessing suppressor functions. Our studies also demonstrate that the adoptive transfer of peripherally-induced regulatory CD8+ T cells into recipient mice may allow for the acceleration of pulmonary metastatic disease, suggesting that CD8+ T regulatory cells are capable of antagonizing antitumor immune responses in mice bearing metastatic melanoma. The findings from these collective studies advance our understanding of how antitumor immune responses may be enhanced through cytokine manipulation strategies, and characterize the molecular signals involved in peripheral CD8+ regulatory T cell development.","Made available in DSpace on 2015-09-28T15:38:29Z (GMT). No. of bitstreams: 2 license.txt: 4848 bytes, checksum: 96035ab3f5e1c23cc7138a224ce498bd (MD5) 3269890.pdf: 4527604 bytes, checksum: e1fe982af2c8a978119fd68fa4a08f65 (MD5) Previous issue date: 2007","Embargo set by: Seth Robbins for item 88414 Lift date: Forever Reason: Restricted to the U of I community idenfinitely during batch ingest of legacy ETDs","Restricted to the U of I community idenfinitely during batch ingest of legacy ETDs","U of I Only","155 p.","Thesis (Ph.D.)--University of Illinois at Urbana-Champaign, 2007."]},{"key":"dc:title","label":"Title","values":["The Participation of Transforming Growth Factor Beta in Tumor Immunoevasion"]}]}],"canonical_facts":{"dc:contributor":["Roy, Edward J."],"dc:creator":["Fan, Timothy M."],"dc:date":["2015-09-28T15:38:29Z","10000-01-01","2007"],"dc:description":["In addition to exploring the clinical utility of combination cytokine therapies for the treatment of cancer, our studies also investigate the molecular mechanisms which participate in the generation of peripheral CD8+CD25 + T regulatory cells. Our findings suggest that in the presence of high concentrations of TGFbeta1, strong costimulatory strength is permissive for the induction of CD8+ T cells possessing suppressor functions. Our studies also demonstrate that the adoptive transfer of peripherally-induced regulatory CD8+ T cells into recipient mice may allow for the acceleration of pulmonary metastatic disease, suggesting that CD8+ T regulatory cells are capable of antagonizing antitumor immune responses in mice bearing metastatic melanoma. The findings from these collective studies advance our understanding of how antitumor immune responses may be enhanced through cytokine manipulation strategies, and characterize the molecular signals involved in peripheral CD8+ regulatory T cell development.","Made available in DSpace on 2015-09-28T15:38:29Z (GMT). No. of bitstreams: 2 license.txt: 4848 bytes, checksum: 96035ab3f5e1c23cc7138a224ce498bd (MD5) 3269890.pdf: 4527604 bytes, checksum: e1fe982af2c8a978119fd68fa4a08f65 (MD5) Previous issue date: 2007","Embargo set by: Seth Robbins for item 88414 Lift date: Forever Reason: Restricted to the U of I community idenfinitely during batch ingest of legacy ETDs","Restricted to the U of I community idenfinitely during batch ingest of legacy ETDs","U of I Only","155 p.","Thesis (Ph.D.)--University of Illinois at Urbana-Champaign, 2007."],"dc:identifier":["http://hdl.handle.net/2142/87133","(MiAaPQ)AAI3269890"],"dc:language":["eng"],"dc:subject":["Health Sciences, Oncology"],"dc:title":["The Participation of Transforming Growth Factor Beta in Tumor Immunoevasion"],"dc:type":["text"],"thesis:degree_discipline":["Veterinary Clinical Medicine"],"thesis:degree_level":["Dissertation"],"thesis:degree_name":["Ph.D."],"thesis:institution_name":["University of Illinois at Urbana-Champaign"]},"updated_at":"2026-07-22T22:26:28Z"}